| Literature DB >> 25877213 |
Koichi Yamamoto1, Akemi Kakino2, Hikari Takeshita2, Norihiro Hayashi2, Lei Li2, Atsushi Nakano2, Hiroko Hanasaki-Yamamoto2, Yoshiko Fujita2, Yuki Imaizumi2, Serina Toyama-Yokoyama2, Chikako Nakama2, Tatsuo Kawai2, Masao Takeda2, Kazuhiro Hongyo2, Ryosuke Oguro2, Yoshihiro Maekawa2, Norihisa Itoh2, Yoichi Takami2, Miyuki Onishi2, Yasushi Takeya2, Ken Sugimoto2, Kei Kamide2, Hironori Nakagami2, Mitsuru Ohishi1, Theodore W Kurtz2, Tatsuya Sawamura2, Hiromi Rakugi2.
Abstract
The angiotensin II type 1 receptor (AT1) is a 7-transmembrane domain GPCR that when activated by its ligand angiotensin II, generates signaling events promoting vascular dysfunction and the development of cardiovascular disease. Here, we show that the single-transmembrane oxidized LDL (oxLDL) receptor (LOX-1) resides in proximity to AT1 on cell-surface membranes and that binding of oxLDL to LOX-1 can allosterically activate AT1-dependent signaling events. oxLDL-induced signaling events in human vascular endothelial cells were abolished by knockdown of AT1 and inhibited by AT1 blockade (ARB). oxLDL increased cytosolic G protein by 350% in Chinese hamster ovary (CHO) cells with genetically induced expression of AT1 and LOX-1, whereas little increase was observed in CHO cells expressing only LOX-1. Immunoprecipitation and in situ proximity ligation assay (PLA) assays in CHO cells revealed the presence of cell-surface complexes involving LOX-1 and AT1. Chimeric analysis showed that oxLDL-induced AT1 signaling events are mediated via interactions between the intracellular domain of LOX-1 and AT1 that activate AT1. oxLDL-induced impairment of endothelium-dependent vascular relaxation of vascular ring from mouse thoracic aorta was abolished by ARB or genetic deletion of AT1. These findings reveal a novel pathway for AT1 activation and suggest a new mechanism whereby oxLDL may be promoting risk for cardiovascular disease. © FASEB.Entities:
Keywords: G protein-coupled receptor; allosteric activation; receptor multimerization; vascular dysfunction
Mesh:
Substances:
Year: 2015 PMID: 25877213 DOI: 10.1096/fj.15-271627
Source DB: PubMed Journal: FASEB J ISSN: 0892-6638 Impact factor: 5.191